The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 15 Jun 2004
doi: 10.1242/jcs.01188
Research Article
Crosslinking and G-protein functions of transglutaminase 2 contribute differentially to fibroblast wound healing responses
Phil Stephens,
Pascale Grenard,
Pascale Aeschlimann,
Martin Langley,
Emma Blain,
Rachael Errington,
David Kipling,
David Thomas,
and
Daniel Aeschlimann*
* Author for correspondence (e-mail: aeschlimanndp{at}cardiff.ac.uk)
Tissue transglutaminase (TG2) affects cell-matrix interactions in cell spreading, migration and extracellular matrix (ECM) reorganisation. Using fibroblasts deficient in TG2 or overexpressing normal or crosslinking-deficient enzyme, we show that the extracellular crosslinking activity and intracellular G-protein function in signal transduction contribute differentially to regulation of cell-matrix interactions. TG2-deficient cells displayed normal attachment but delayed spreading on ECM substrata and defects in motility unrelated to crosslinking. Blocking antibodies to TG2 failed to induce similar defects in normal fibroblasts. TG2-deficient fibroblasts had defects in focal adhesion turnover and stress fibre formation, showed changes in focal adhesion kinase (FAK) phosphorylation and failed to activate protein kinase C 
(PKC). Phospholipase C (PLC) and PKC inhibitors blocked spreading of normal fibroblasts whilst PKC activators induced spreading in TG2-deficient cells. In contrast, ECM remodelling was not only compromised by TG2 deficiency but also by overexpression of dominant negative enzyme and TG inhibitors. TG2 activity increased matrix tension and was required for membrane type 1-MMP (MT1-MMP)-dependent activation of MMP-2. Our results demonstrate that TG2 is involved in the control of dynamic adhesion formation in cell spreading and migration via regulation of phospholipase C activity. By virtue of its crosslinking activity, the enzyme plays a central role in regulating ECM remodelling.
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati 
Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
D. Telci, R. J. Collighan, H. Basaga, and M. Griffin
Increased TG2 Expression Can Result in Induction of Transforming Growth Factor {beta}1, Causing Increased Synthesis and Deposition of Matrix Proteins, Which Can Be Regulated by Nitric Oxide
J. Biol. Chem.,
October 23, 2009;
284(43):
29547 - 29558.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Scarpellini, R. Germack, H. Lortat-Jacob, T. Muramatsu, E. Billett, T. Johnson, and E. A. M. Verderio
Heparan Sulfate Proteoglycans Are Receptors for the Cell-surface Trafficking and Biological Activity of Transglutaminase-2
J. Biol. Chem.,
July 3, 2009;
284(27):
18411 - 18423.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. E. Iismaa, B. M. Mearns, L. Lorand, and R. M. Graham
Transglutaminases and Disease: Lessons From Genetically Engineered Mouse Models and Inherited Disorders
Physiol Rev,
July 1, 2009;
89(3):
991 - 1023.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. CHHABRA, A. VERMA, and K. MEHTA
Tissue Transglutaminase Promotes or Suppresses Tumors Depending on Cell Context
Anticancer Res,
June 1, 2009;
29(6):
1909 - 1919.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Y. Hwang, L. S. Mangala, J. Y. Fok, Y. G. Lin, W. M. Merritt, W. A. Spannuth, A. M. Nick, D. J. Fiterman, P. E. Vivas-Mejia, M. T. Deavers, et al.
Clinical and Biological Significance of Tissue Transglutaminase in Ovarian Carcinoma
Cancer Res.,
July 15, 2008;
68(14):
5849 - 5858.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. R. Fiedler, E. Schonherr, R. Waddington, S. Niland, D. G. Seidler, D. Aeschlimann, and J. A. Eble
Decorin Regulates Endothelial Cell Motility on Collagen I through Activation of Insulin-like Growth Factor I Receptor and Modulation of {alpha}2{beta}1 Integrin Activity
J. Biol. Chem.,
June 20, 2008;
283(25):
17406 - 17415.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T.-C. Hsu, S.-Y. Chiang, C.-Y. Huang, G. J. Tsay, C.-W. Yang, C.-N. Huang, and B.-S. Tzang
Beneficial Effects of Treatment with Transglutaminase Inhibitor Cystamine on Macrophage Response in NZB/W F1 Mice
Experimental Biology and Medicine,
February 1, 2007;
232(2):
195 - 203.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Z. Balajthy, K. Csomos, G. Vamosi, A. Szanto, M. Lanotte, and L. Fesus
Tissue-transglutaminase contributes to neutrophil granulocyte differentiation and functions
Blood,
September 15, 2006;
108(6):
2045 - 2054.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. D. Amatangelo, D. E. Bassi, A. J.P. Klein-Szanto, and E. Cukierman
Stroma-Derived Three-Dimensional Matrices Are Necessary and Sufficient to Promote Desmoplastic Differentiation of Normal Fibroblasts
Am. J. Pathol.,
August 1, 2005;
167(2):
475 - 488.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. A. Johnson and R. A. Terkeltaub
External GTP-bound Transglutaminase 2 Is a Molecular Switch for Chondrocyte Hypertrophic Differentiation and Calcification
J. Biol. Chem.,
April 15, 2005;
280(15):
15004 - 15012.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2004
